Ablation Devices Market - By Technology (Radiofrequency Devices, Laser/Light Ablation, Ultrasound Devices, Cryoablation Devices), By Application (Cardiology, Oncology, Ophthalmology, Gynecology), By End-use & Global Forecast, 2023-2032

Ablation Devices Market Size

Ablation Devices Market size garnered over USD 8.6 billion in revenues in 2022 and is predicted to exhibit above 9% CAGR from 2023 to 2032. A noticeable surge in the incidences of chronic diseases worldwide is one of the key factors contributing to the growing demand for ablation devices.
 

The rapid adoption of an unhealthy lifestyle, excessive tobacco and alcohol intake, smoking habits, substance abuse, high caffeine consumption, and others have resulted in the growing prevalence of several chronic disorders. According to the World Health Organization estimates, tobacco-related cardiac diseases claim the lives of more than 1.9 million individuals globally every year. The commendable rise in disease burden has aggravated the number of patients undergoing treatment across healthcare settings, which, in consequence, has benefited the market progress.
 

Minimally invasive procedures have gained significant popularity over the years due to the involvement of fewer complications and smaller surgical incisions. These procedures ensure efficient post-surgical pain management, reduced hospital stays, faster recovery, and better prognosis than traditional interventions. Several advancements in minimally invasive surgeries are projected to accelerate industry trends.
 

Strict regulatory framework to impede ablation devices market development

However, stringent regulatory approvals associated with ablation devices may act as a growth restraining factor over the next ten years. Regulatory approvals for ablation devices are often time-consuming and may require high capital investment. Ablation devices are classified under the Class II devices category involving moderate to high risk by the U.S. Food and Drugs Administration (FDA). Additionally, the European Medicines Agency (EMA) classifies these devices as class III products, possessing the highest level of risk. Therefore, these devices cannot be launched into the market for customer use without FDA or EMA approvals. If authorizations are delayed or denied, they result in the loss of time and money to the manufacturers, thus, leading to sluggish expansion.
 

Ablation Devices Market Analysis

Ablation devices market share from the radiofrequency devices segment is primed to grow at over 8.5% CAGR between 2023 and 2032. Radiofrequency devices find widespread usage in the field of oncology, cardiology, cosmetology, gynecology, and pain management. The growing prominence of cardiovascular diseases, primarily atrial fibrillation, has boosted the demand for radiofrequency devices. The high success rate of procedures with the use of radiofrequency devices in the treatment of atrial fibrillation has increased the product adoption rate, which will favor segment outlook.
 

Ablation devices market size from the cardiology segment was valued at over USD 3.5 billion in 2022 and is foreseen to grow at more than 9% CAGR during 2023-2032. The growing patient population suffering from severe heart-related disorders such as atrial fibrillation and tachycardia, among others, will enhance the segment growth potential with procedural demand. For instance, according to the Centers for Disease Prevention and Control, around 6.5 million people die due to cardiac conditions every year in the U.S.

Hospitals are likely to emerge as one of the promising end-users of ablation devices, with the segment poised to attain a valuation of USD 11.3 billion by 2032. The incidence rate of ablation procedures is considerably high in hospital settings as these establishments ensure the availability of skilled healthcare professionals and advanced equipment, reducing the complexity of the procedure. Additionally, innovative product launches in the ablation industry and extending government support toward improving the hospital infrastructure will aid segment share.
 

North America ablation devices market is set to witness over 9% CAGR through 2032. Increasing adoption of cutting-edge technologies, coupled with the presence of the most highly developed countries providing state-of-the-art facilities for conducting minimally invasive cardiac procedures, will influence regional landscape. Moreover, the high disposable incomes and increasing healthcare expenditure are also some of the factors supporting the market expansion in the region.
 

Ablation Devices Market Share

Notable players in the ablation devices industry are :

• Abbott Laboratories
• Angiodynamics,
• Atricure Inc.
•   Alcon Laboratories
• Bausch & Lomb Incorporated
• Biotronik SE & Co. KG
• CONMED Corporation
• Elekta AB.
• Olympus Corporation
• Varian
• Ethicon
• Inc (Johnson & Johnson)
• Medtronic plc
• Boston Scientific Corporation
   

The ablation devices market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By technology

• Radiofrequency devices
• Laser/light ablation
• Ultrasound devices
• Cryoablation devices
• Others

By application

• Cardiology
• Oncology
• Ophthalmology
• Gynecology
• Urology
• Cosmetic surgery
• Others

By end-use

• Hospitals
• Ambulatory surgery centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Switzerland
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel